<i>In Vitro</i> Activity of Manogepix (APX001A) and Comparators against Contemporary Molds: MEC Comparison and Preliminary Experience with Colorimetric MIC Determination
Karin Meinike Jørgensen, Karen Marie Thyssen Astvad, Maiken Cavling Arendrup
Abstract
Manogepix (APX001A) is the active moiety of the drug candidate fosmanogepix (APX001), currently in clinical development for the treatment of invasive fungal infections. We compared manogepix EUCAST minimum effective concentrations (MECs) to MICs of five comparators and CLSI MECs and MICs by a colorimetric method against contemporary molds. EUCAST susceptibility testing was performed for 161 isolates. Interlaboratory and intermethod reproducibility were determined by comparison with published manogepix MECs.
Topics & Concepts
PosaconazoleMicrobiologyBroth microdilutionSerial dilutionAspergillus fumigatusAspergillusBiologyItraconazoleFusariumMinimum inhibitory concentrationMedicineAntibioticsAntifungalBotanyPathologyAlternative medicineAntifungal resistance and susceptibilityMicrobial Natural Products and BiosynthesisPlant Pathogens and Fungal Diseases